Edition:
United States

Insider Trading: Albany Molecular Research Inc (AMRI.O)

AMRI.O on Nasdaq

17.24USD
6 Dec 2016
Change (% chg)

-- (--)
Prev Close
$17.24
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
246,846
52-wk High
$20.59
52-wk Low
$12.45

All Insider Trades
Trading Date Name Title Type Shares Traded Price
29 Nov 2016

Hagen (Steven R)

Officer Sell 9,000 $16.71
29 Nov 2016

Hagen (Steven R)

Officer Buy 9,000 $13.20
15 Nov 2016

Henderson (Lori M)

General Counsel Sell 6,000 $17.00
13 Nov 2016

D'Ambra (Thomas E)

Chairman of the Board Gift 10,000 $0.00
9 Nov 2016

D'Ambra (Thomas E)

Chairman of the Board Gift 2,000 $0.00
9 Nov 2016

D'Ambra (Thomas E)

Chairman of the Board Gift 700 $0.00
9 Nov 2016

Hagen (Steven R)

Officer Sell 785 $16.79
1 Nov 2016

Henderson (Lori M)

General Counsel Sell 409 $15.09
1 Nov 2016

Hagen (Steven R)

Officer Sell 465 $15.09
1 Nov 2016

Svokos (George)

Chief Operating Officer Sell 817 $15.09
4 Oct 2016

Ryan (Una S)

Director Buy 5,000 $11.83
4 Oct 2016

Ryan (Una S)

Director Sell 3,498 $16.91
8 Aug 2016

Hagen (Steven R)

Officer Sell 1,401 $15.29
4 Jul 2016

Svokos (George)

Chief Operating Officer Buy 1,312 $11.42
4 Jul 2016

Marth (William S)

Chief Executive Officer Buy 1,312 $11.42
14 Jun 2016

O'Connor (Kevin)

Director Buy 1,518 $14.82
14 Jun 2016

Hagen (Kenneth Paul CPA)

Director Buy 3,036 $14.82
14 Jun 2016

Deming (David H)

Director Buy 3,036 $14.82
14 Jun 2016

Maddaluna (Anthony J)

Director Buy 3,036 $14.82
14 Jun 2016

Ryan (Una S)

Director Buy 4,048 $14.82
30 May 2016

O'Connor (Kevin)

Director Buy 5,000 $10.37
30 May 2016

O'Connor (Kevin)

Director Sell 5,000 $14.41
30 May 2016

Roth (Arthur J)

Director Buy 5,000 $10.37
30 May 2016

Roth (Arthur J)

Director Sell 3,576 $14.50
15 May 2016

Marth (William S)

Chief Executive Officer Buy 12,500 $12.86

Institutional Holders

% Shares Owned: 72.43%
# of Holders: 200
Total Shares Held: 31,066,932
3 Mo. Net Change: 31,951
# New Positions: 12
# Closed Positions: 21
# Increased Positions: 73
# Reduced Positions: 79
# Net Buyers: -6

Officers & Directors

Name Age Since Current Position

Thomas D' Ambra

59 2013 Non-Executive Chairman of the Board

William Marth

60 2014 President, Chief Executive Officer, Director

Felicia Ladin

43 2015 Chief Financial Officer, Senior Vice President, Treasurer

Lori Henderson

53 2011 Senior Vice President, General Counsel, Secretary

Christopher Conway

2015 Senior Vice President - Discovery and Development and Global Commercial Sales

Milton Boyer

2015 Senior Vice President - Drug Product Manufacturing

Steven Hagen

54 2012 Senior Vice President - Manufacturing and Pharmaceuticals

George Svokos

57 2015 Chief Commercial Officer and Senior Vice President, API

Jimmy Wang

2015 Chief Information Officer

Una Ryan

73 2010 Lead Independent Director

David Deming

62 2016 Director

Gerardo Gutierrez

2015 Director

Kenneth Hagen

2016 Director

Anthony Maddaluna

63 2016 Director

Fernando Napolitano

49 2016 Director

Kevin O' Connor

60 2000 Independent Director

Arthur Roth

75 2003 Independent Director